Cardiometabolic Disorders News

The American Heart Association unveiled a new term to reflect the interplay of several metabolic and renal conditions driving risk for CVD, along with an updated algorithm and guidance for screening, management and collaborative care.

Adults with obesity receiving tirzepatide lost more than 25% of their body weight and were able to maintain their weight loss for up to 88 weeks, according to data from the SURMOUNT-4 trial.

Spending more time in natural light may help improve metabolism for adults with type 2 diabetes, according to data from a small study presented at the European Association for the Study of Diabetes annual meeting.

PHILADELPHIA — In this video exclusive, Stephanie Faubion, MD, MBA, FACP, NCMP, IF, provides pearls for use of menopausal hormone therapy by women with chronic conditions.

Healio continues its partnership with Cardiometabolic Health Congress in support of the much-anticipated 18th Annual Cardiometabolic Health Congress: Social Determinants and Digital Advances in Cardiorenal Metabolic Health in October.

PHILADELPHIA — In this video exclusive, Nanette Santoro, MD, discussed efficacy for different groups of women of a nonhormonal neurokinin 3 receptor antagonist recently approved by the FDA to treat moderate to severe hot flashes.

PHILADELPHIA — In this video exclusive, Cynthia A. Stuenkel, MD, MSCP, talks about selecting therapies for menopausal symptoms for women with a history of cardiovascular disease.

Older adults with type 2 diabetes are less likely to have a cardiovascular event if they are initially prescribed an SGLT2 inhibitor or GLP-1 receptor agonist instead of a DPP-IV inhibitor, according to findings published in Diabetes Care.

Tirzepatide induced greater HbA1c and body weight reductions vs. placebo than semaglutide for people with type 2 diabetes, according to data that will be presented at the European Association for the Study of Diabetes annual meeting.

Genetic predisposition to denture use was associated with increased likelihood of cardiometabolic diseases and related risk factors including dyslipidemia and elevated waist circumference, researchers reported.